Onward Med Nv (ONWRF) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Onward Medical N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.217 -- 00:00:04.882 Good morning, good afternoon everyone and welcome to our Onwards webcast following the 00:00:04.882 -- 00:00:10.047 publication of our results earlier today. As usual, before we get started, please take 00:00:10.047 -- 00:00:13.971 a moment to read our disclaimer. Today's presentation 00:00:13.971 -- 00:00:17.655 includes forward-looking statements which should be considered with the appropriate level 00:00:17.655 -- 00:00:22.760 of caution as outlined on this page. The slides and its recording will 00:00:22.760 -- 00:00:27.002 be available on our website after the call. 00:00:27.324 -- 00:00:32.841 Today's speaker includes Dave, our CEO, Sean Chiara, 00:00:32.841 -- 00:00:38.150 our Chief Commercial Officer, and Amory Fraser, our Senior Finance Director. 00:00:38.150 -- 00:00:41.776 As usual, we go through a comprehensive update 00:00:41.776 -- 00:00:47.365 before opening for questions. You may submit your questions verbally or via the Q&A module 00:00:47.365 -- 00:00:50.711 on the platform. With that, I'll hand over to Dave. 00:00:50.711 -- 00:00:52.711 Thank 00:00:53.095 -- 00:00:57.693 you, Seb. So it was an eventful quarter four onward. 00:00:57.693 -- 00:01:03.441 Since our last update, we exceeded 1.5 million euros in quarterly revenue. 00:01:03.441 -- 00:01:08.628 We received CE mark and U.S. home use clearance from FDA for the 00:01:08.628 -- 00:01:13.675 Archaic system, and we raised 50 million euros in new equity capital. 00:01:13.675 -- 00:01:18.461 So let me just run through these in a bit more detail, and then I'll also go into further 00:01:18.461 -- 00:01:21.605 detail during the presentation that follows. 00:01:21.605 -- 00:01:25.655 So most importantly for most of you is commercial traction. 00:01:25.655 -- 00:01:...